STOCK TITAN

Transport Media Market to Reach $12.59 Billion by 2028; COVID-19 Pandemic Reshaping the Market Demand - Arizton

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
covid-19

CHICAGO, March 9, 2023 /PRNewswire/ -- Arizton's latest research report states that the transport media market was valued at $13 billion in 2022.

TO KNOW MORE, DOWNLOAD THE FREE SAMPLE REPORT: https://www.arizton.com/request-sample/3739

BROWSE IN-DEPTH TOC ON THE TABLETOP GAMES MARKET

327 - Pages
159 - Tables 
130 – Charts

Transport media are specially designed, scientifically created media formulated to preserve a biospecimen sample and reduce bacterial overgrowth from collection until they are received at a lab for further processing. Transport media can vary depending on the type of organism that is thought to be present in the sample. The market for transport media attributed the growth to several factors that continuously fuel market growth. Additionally, the transport media's development underwent several rapid changes that created opportunities for market expansion during the forecast period.

TRANSPORT MEDIA MARKET REPORT SCOPE

Report Attributes

Details

Market Size (2028)

USD 12.59 Billion

Market Size (2022)

USD 13.15 Billion

CAGR (2022-2028)

(0.73 %)

Base Year

2022

Forecast Year

2023-2028

Market Segments

Product, Application, Indication, End-Users, and Geography

Geographic Analysis

North America, Europe, APAC, Latin America, and Middle East & Africa

Market Dynamics

·  Impacts of COVID-19

·  Increasing Prevalence of Infectious Diseases

·  Increasing Diagnosis Rate for Infectious Diseases

 

LOOKING FOR MORE INFO? DOWNLOAD THE FREE SAMPLE REPORT NOW: https://www.arizton.com/request-sample/3739

IMPACT OF COVID-19

The COVID-19 pandemic positively impacted the transport media market globally. Several rapid changes were addressed from 2020 to 2022 and are expected to influence market growth positively. The rapid surge of COVID-19 significantly increased the demand for medium transport solutions, such as viral transport medium (VTM), molecular transport medium (MTM), and universal transport medium (UTM). The production rate of transport media increased significantly, and viral transport medium accounted for higher demand.

INCREASING RESEARCH & FOCUS ON VIRAL TRANSPORT MEDIA

The rapid surge of the COVID-19 pandemic globally tremendously increased research and development and focused on diagnosing SARS-COV-2. It resulted in the rapidly increased research & development for viral transport medium.  Several new viral transport medium solutions were introduced in the market. Some solutions are specifically developed for the COVID-19 virus, and some are launched for other viruses with COVID-19. It gives significant development and research in the market and delivers new growth opportunities.

The emergence of the COVID-19 pandemic places a major burden on research and the supply of viral transport mediums. The increase in the viral transport medium (VTM) requirement and the preparation for a new VTM transport medium aggressively noted and expanded for diagnostic and testing purposes. The manual handling of viral transport medium and their production, including sterilization and filling, was significantly optimized. At the same time, the Center for Disease Control and Prevention (CDC) has drafted newly developed standard operating procedures for developing VTM and stated that the VTM must sustain virus integrity and suppress contaminating microorganisms, which might interfere with testing and diagnosis.

CUSTOMIZATION AVAILABLE

If our report does not include the information you are searching for, you may contact us to have a report tailored to your specific business needs https://www.arizton.com/customize-report/3739

North America's transport media market will reach $3 billion by 2028. North America dominates the transport media market due to the increased prevalence of viral infectious diseases and associated population, high diagnostic and preclinical testing rate, and increased focus on R&D in the region on viral diseases boosts the market growth. In North America, several domestic to global market players of VTM, UTM, and MTM came forward to fulfill the demand for transport media solutions during the pandemic and accounted for significant revenue. At the same time, advances in transport media by the market players and health and research authorities offer standard protocols for transport media products, increase production in higher volume, and generate higher revenue in the region.

KEY COMPANY PROFILES

  • BD
  • Hardy Diagnostics
  • HiMedia Laboratories
  • Laboratory Corporation of America
  • Puritan Medica Products
  • Thermo Fisher Scientific
  • Vircell
  • AB Medical
  • Alpha-Tec Systems
  • AccuGene USA
  • Apical Scientific
  • Azooka Labs
  • Biomed Diagnostics
  • bioBoaVista
  • BioGenex
  • BIOLOGIX Group
  • BIOCOMMA
  • Charm Sciences
  • Creative Life Sciences
  • Citotest Labware Manufacturing
  • CPT Medical
  • COPAN Diagnostics
  • DiaSorin Molecular
  • EKF Diagnostics Holding
  • Ensol Biosciences
  • General Biologics
  • Gentueri
  • Han Chang Medic
  • Hebei Chaoran Medical Instruments
  • Innolyzer Labs
  • KSL Diagnostics
  • Lucence Health
  • LaunchWorks
  • Liofilchem
  • Medical Wire & Equipment
  • Miraclean Technology
  • MetaDesign Solutions
  • Quidel Corporation
  • Trinity Biotech
  • Manila HealthTek
  • MATTEK
  • Nodford International
  • Starplex Scientific
  • Sansure Biotech
  • Sisco Research Laboratories
  • Teknova
  • Titan Biotech
  • Vegas Biotech
  • Yocon Biology Technology Company
  • Zybio

MARKET SEGMENTATION

Product

  • Viral Transport Media
  • Universal Transport Media
  • Molecular Transport Media

Application

  • Diagnosis
  • Pre-clinical Testing

Indication

  • Viral Diseases
  • Non-Viral Diseases

End-users

  • Diagnostic Labs
  • Hospitals & Clinics
  • Others

Geography

  • North America
    • The US
    • Canada
  • Europe
    • The UK
    • Italy
    • France
    • Spain
    • Germany
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey

CHECK OUT SOME OF THE TOP-SELLING RESEARCH REPORTS:

In Vitro Diagnostics Market - Global Outlook & Forecast 2023-2028: The global in vitro diagnostics market is expected to reach USD 127.56 billion by 2028. Advances in molecular diagnostics are transforming the future of healthcare, increasing demand for companion diagnostics in IVD, and increasing product launches & mergers & acquisitions are trends in the in-vitro diagnostics market.

Viral Transport Medium Market - Global Outlook & Forecast 2022-2027: The global viral transport medium market is expected to reach USD 5.6 billion by 2027. The increasing prevalence of infectious diseases, diagnosis rates for viral infectious diseases, and a surge in covid-19 infections are the major growth factors driving the global viral transport medium market.

Medical Swab Market - Global Outlook & Forecast 2022-2027: The medical swab market is forecasted to reach USD 1.48 billion by 2027. COVID-19 has hosted the demand for swabs across the globe. An increase in the number of research labs and diagnostic centers raising the prevalence of hospital-acquired infections are some of the major driving factors in the global medical swabs market. 

COVID-19 Diagnostics Market - Global Outlook and Forecast 2021-2026: The global COVID-19 diagnostics market is expected to reach USD 7.4 billion by 2026. Adopting a population-wide testing approach, which includes household, individual testing, is one of the trends influencing the demand for a covid-19 diagnostics kit.

TABLE OF CONTENT

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET BY PRODUCT SEGMENT

4.3.2 MARKET BY APPLICATION SEGMENT

4.3.3 MARKET BY INDICATION SEGMENT

4.3.4 MARKET BY END-USERS

4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

6.1 OVERVIEW

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

9.1 NEW PRODUCT LAUNCHED FOR TRANSPORT MEDIA

9.2 TECHNOLOGICAL ADVANCES IN TRANSPORT MEDIA

9.3 RAPID ACCELERATION OF DIAGNOSTICS AND FUNDING DURING PANDEMIC

9.4 INCREASING RESEARCH AND FOCUS ON VIRAL TRANSPORT MEDIA

10 MARKET GROWTH ENABLERS

10.1 IMPACTS OF COVID-19

10.2 INCREASING PREVALENCE OF INFECTIOUS DISEASES

10.3 INCREASING DIAGNOSIS RATE FOR INFECTIOUS DISEASES

11 MARKET RESTRAINTS

11.1 AVAILABLE ALTERNATIVE SOLUTIONS FOR TRANSPORT MEDIA

11.2 LIMITED ACCESS TO DIAGNOSTIC SERVICES IN LMICS

11.3 CHALLENGES ASSOCIATED WITH TRANSPORT MEDIA

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 INSIGHTS BY PRODUCT

12.2.2 INSIGHTS BY APPLICATION

12.2.3 INSIGHTS BY INDICATION

12.2.4 INSIGHTS BY END-USERS

12.2.5 INSIGHTS BY GEOGRAPHY

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 VIRAL TRANSPORT MEDIA (VTM)

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 UNIVERSAL TRANSPORT MEDIA (UTM)

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

13.5 MOLECULAR TRANSPORT MEDIA (MTM)

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MARKET BY GEOGRAPHY

13.6 OTHERS

13.6.1 MARKET OVERVIEW

13.6.2 MARKET SIZE & FORECAST

13.6.3 MARKET BY GEOGRAPHY

14 APPLICATION

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 DIAGNOSIS

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 PRECLINICAL TESTINGS

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

15 INDICATION

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 VIRAL DISEASES

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 NON-VIRAL DISEASE

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

16 END-USERS

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 DIAGNOSTIC LABS

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.3.3 MARKET BY GEOGRAPHY

16.4 HOSPITALS AND CLINICS

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.4.3 MARKET BY GEOGRAPHY

16.5 OTHERS

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.5.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

17.1 MARKET SNAPSHOT & GROWTH ENGINE

17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 PRODUCT

18.3.1 MARKET SIZE & FORECAST

18.4 APPLICATION

18.4.1 MARKET SIZE & FORECAST

18.5 INDICATION

18.5.1 MARKET SIZE & FORECAST

18.6 END-USERS

18.6.1 MARKET SIZE & FORECAST

18.7 KEY COUNTRIES

18.7.1 US: MARKET SIZE & FORECAST

18.7.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 PRODUCT

19.3.1 MARKET SIZE & FORECAST

19.4 APPLICATION

19.4.1 MARKET SIZE & FORECAST

19.5 INDICATION

19.5.1 MARKET SIZE & FORECAST

19.6 END-USERS

19.6.1 MARKET SIZE & FORECAST

19.7 KEY COUNTRIES

19.7.1 UK: MARKET SIZE & FORECAST

19.7.2 ITALY: MARKET SIZE & FORECAST

19.7.3 FRANCE: MARKET SIZE & FORECAST

19.7.4 GERMANY: MARKET SIZE & FORECAST

19.7.5 SPAIN: MARKET SIZE & FORECAST

20 APAC

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 PRODUCT

20.3.1 MARKET SIZE & FORECAST

20.4 APPLICATION

20.4.1 MARKET SIZE & FORECAST

20.5 INDICATION

20.5.1 MARKET SIZE & FORECAST

20.6 END-USERS

20.6.1 MARKET SIZE & FORECAST

20.7 KEY COUNTRIES

20.7.1 CHINA: MARKET SIZE & FORECAST

20.7.2 JAPAN: MARKET SIZE & FORECAST

20.7.3 INDIA: MARKET SIZE & FORECAST

20.7.4 AUSTRALIA: MARKET SIZE & FORECAST

20.7.5 SOUTH KOREA: MARKET SIZE & FORECAST

21 LATIN AMERICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 PRODUCT

21.3.1 MARKET SIZE & FORECAST

21.4 APPLICATION

21.4.1 MARKET SIZE & FORECAST

21.5 INDICATION

21.5.1 MARKET SIZE & FORECAST

21.6 END-USERS

21.6.1 MARKET SIZE & FORECAST

21.7 KEY COUNTRIES

21.7.1 BRAZIL: MARKET SIZE & FORECAST

21.7.2 MEXICO: MARKET SIZE & FORECAST

21.7.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST AFRICA

22.1 MARKET OVERVIEW

22.2 MARKET SIZE & FORECAST

22.3 PRODUCT

22.3.1 MARKET SIZE & FORECAST

22.4 APPLICATION

22.4.1 MARKET SIZE & FORECAST

22.5 INDICATION

22.5.1 MARKET SIZE & FORECAST

22.6 END-USERS

22.6.1 MARKET SIZE & FORECAST

22.7 KEY COUNTRIES

22.7.1 TURKEY: MARKET SIZE & FORECAST

22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST

22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

23.1 COMPETITION OVERVIEW

23.2 MARKET SHARE ANALYSIS

23.2.1 BD

23.2.2 HARDY DIAGNOSTICS

23.2.3 HIMEDIA LABORATORIES

23.2.4 LABORATORY CORPORATION OF AMERICA

23.2.5 PURITAN MEDICAL PRODUCTS

23.2.6 THERMO FISHER SCIENTIFIC

23.2.7 VIRCELL

24 KEY COMPANY PROFILES

24.1 BD

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERINGS

24.1.3 KEY STRATEGIES

24.1.4 KEY STRENGTHS

24.1.5 KEY OPPORTUNITIES

24.2 HARDY DIAGNOSTICS

24.3 HIMEDIA LABORATORIES

24.4 LABORATORY CORPORATION OF AMERICA

24.5 PURITAN MEDICAL PRODUCTS

24.6 THERMO FISHER SCIENTIFIC

24.7 VIRCELL

25 OTHER PROMINENT VENDORS

25.1 AB MEDICAL

25.1.1 BUSINESS OVERVIEW

25.1.2 PRODUCT OFFERINGS

25.2 ALPHA-TEC SYSTEMS

25.3 ACCUGENE USA

25.4 APICAL SCIENTIFIC

25.5 AZOOKA LABS

25.6 BIOMED DIAGNOSTICS

25.7 BIOBOAVISTA

25.8 BIOGENEX

25.9 BIOLOGIX GROUP

25.10 BIOCOMMA

25.11 CHARM SCIENCES

25.12 CREATIVE LIFE SCIENCES CO., LTD.

25.13 CITOTEST LABWARE MANUFACTURING

25.14 CPT MEDICAL

25.15 COPAN DIAGNOSTICS

25.16 DIASORIN MOLECULAR

25.17 EFK DIAGNOSTICS HOLDING

25.18 ENSOL BIOSCIENCES

25.19 GENERAL BIOLOGICS

25.20 GENTUERI

25.21 HANG CHANG MEDIC

25.22 HEBEI CHAORAN MEDICAL INSTRUMENTS

25.23 INNOLYZER LABS

25.24 KSL DIAGNOSTICS

25.25 LUCENCE HEALTH

25.26 LAUNCHWORKS

25.27 LIOFILCHEM

25.28 MEDICAL WIRE & EQUIPMENT

25.29 MIRACLEAN TECHNOLOGY

25.30 METADESIGN SOLUTIONS

25.31 QUIDEL CORPORATION

25.32 TRINITY BIOTECH

25.33 MANILA HEALTHTEK

25.34 MATTEK

25.35 NODFORD INTERNATIONAL

25.36 STARPLEX SCIENTIFIC

25.37 SANSURE BIOTECH

25.38 SISCO RESEARCH LABORATORIES

25.39 TEKNOVA

25.40 TITAN BIOTECH

25.41 VEGAS BIOTECH

25.42 YOCON BIOLOGY TECHNOLOGY COMPANY

25.43 ZYBIO

26 REPORT SUMMARY

26.1 KEY TAKEAWAYS

26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

27.1 MARKET BY GEOGRAPHY

27.2 MARKET BY PRODUCT

27.3 MARKET BY APPLICATION

27.4 MARKET BY INDICATION

27.5 MARKET BY END-USERS

27.6 PRODUCT: MARKET BY GEOGRAPHY

27.6.1 VIRAL TRANSPORT MEDIA: MARKET BY GEOGRAPHY

27.6.2 UNIVERSAL TRANSPORT MEDIA: MARKET BY GEOGRAPHY

27.6.3 MOLECULAR TRANSPORT MEDIA: MARKET BY GEOGRAPHY

27.6.4 OTHER TRANSPORT MEDIA: MARKET BY GEOGRAPHY

27.7 APPLICATION: MARKET BY GEOGRAPHY

27.7.1 DIAGNOSIS: MARKET BY GEOGRAPHY

27.7.2 PRE-CLINICAL TESTING: MARKET BY GEOGRAPHY

27.8 INDICATION: MARKET BY GEOGRAPHY

27.8.1 VIRAL DISEASE: MARKET BY GEOGRAPHY

27.8.2 NON-VIRAL DISEASE: MARKET BY GEOGRAPHY

27.9 END-USERS: MARKET BY GEOGRAPHY

27.9.1 DIAGNOSTIC LABS: MARKET BY GEOGRAPHY

27.9.2 HOSPITALS & CLINICS: MARKET BY GEOGRAPHY

27.9.3 OTHER END-USERS: MARKET BY GEOGRAPHY

28 APPENDIX

28.1 ABBREVIATIONS

ABOUT US:        

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.      

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.       

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.       

CONTACT US :

Call: +1-312-235-2040    
          +1 302 469 0707   
Mail: enquiry@arizton.com     
Contact Us: https://www.arizton.com/contact-us     
Blog: https://www.arizton.com/blog     
Website: https://www.arizton.com/   

Photo:https://mma.prnewswire.com/media/2029458/Transport_Media_Market.jpg
Logo:https://mma.prnewswire.com/media/2029457/Azizton_Logo.jpg

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/transport-media-market-to-reach-12-59-billion-by-2028-covid-19-pandemic-reshaping-the-market-demand---arizton-301767828.html

SOURCE Arizton Advisory & Intelligence

Trinity Biotech Plc

NASDAQ:TRIB

TRIB Rankings

TRIB Latest News

TRIB Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
Ireland
Bray

About TRIB

since its formation in 1992, trinity biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products. the test kits manufactured by trinity biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. the company is also a significant provider of raw materials to the life sciences industry. trinity biotech, which has its headquarters in ireland, employs in excess of 350 people and markets its portfolio of over 400 products to customers in 80 countries around the world. it reaches this worldwide market by combining the